Bifidobacterium animalis DN-173 010

Bifidobacterium animalis DN-173 010 is a clinically studied probiotic strain that produces beneficial metabolites like short-chain fatty acids and bacteriocins. It enhances gut barrier function and modulates immune responses through interaction with intestinal epithelial cells and immune tissue.

Category: Other Evidence: 8/10 Tier: Tier 1 (authoritative)
Bifidobacterium animalis DN-173 010 — Hermetica Encyclopedia

Origin & History

Bifidobacterium animalis DN-173 010 is a probiotic strain commonly found in the human gastrointestinal tract. It is part of the Bifidobacterium genus, which plays a crucial role in maintaining gut health.

Historical & Cultural Context

Bifidobacterium strains have been used in fermented foods and supplements for decades, valued for their health-promoting properties. They are a staple in many probiotic yogurts and dairy products.

Health Benefits

- Supports digestive health by enhancing gut flora balance, improving digestion and nutrient absorption. This balance can reduce bloating and discomfort. - May improve immune function by boosting antibody production. This can decrease the incidence of infections by up to 25%. - Reduces inflammation by modulating cytokine production. This may help alleviate symptoms of inflammatory bowel conditions. - Enhances skin health by reducing systemic inflammation. This can lead to clearer, more radiant skin. - Supports mental health by producing neurotransmitters like serotonin. This can enhance mood and cognitive function. - Aids in weight management by influencing the gut-brain axis. This may help regulate appetite and reduce cravings. - Promotes oral health by inhibiting harmful bacteria growth in the mouth. This can lead to fresher breath and reduced risk of cavities.

How It Works

Bifidobacterium animalis DN-173 010 adheres to intestinal epithelial cells and produces short-chain fatty acids (acetate, butyrate) that strengthen the gut barrier and regulate immune function. The strain stimulates secretory IgA production and modulates cytokine release through Toll-like receptor signaling pathways. It also produces bacteriocins that inhibit pathogenic bacteria growth while promoting beneficial microflora colonization.

Scientific Research

Studies suggest Bifidobacterium animalis DN-173 010 can improve gut health and bolster immune responses. Clinical trials have shown its efficacy in reducing IBS symptoms.

Clinical Summary

Multiple randomized controlled trials involving over 2,000 participants have demonstrated the efficacy of Bifidobacterium animalis DN-173 010. Studies show significant improvements in digestive transit time (reduced by 20-30%) and reduced gastrointestinal discomfort in healthy adults. Clinical trials report up to 25% reduction in respiratory infections and enhanced antibody responses following vaccination. The evidence base includes both short-term (2-4 weeks) and longer-term (12+ weeks) intervention studies with consistent positive outcomes.

Nutritional Profile

- Contains live beneficial bacteria. - Rich in probiotics. - Supports the microbiome balance.

Preparation & Dosage

Recommended dosage is 1-10 billion CFUs per day. Consult a healthcare provider before use.

Synergy & Pairings

Inulin, Lactobacillus acidophilus, Bifidobacterium lactis

Safety & Interactions

Bifidobacterium animalis DN-173 010 is generally well-tolerated with minimal side effects, occasionally causing mild bloating or gas during initial supplementation. No significant drug interactions have been reported, though immunocompromised individuals should consult healthcare providers before use. The strain is considered safe during pregnancy and breastfeeding based on its natural presence in human microbiota. Individuals with severe acute pancreatitis or compromised intestinal barrier function should exercise caution.